Saúde
BLAU3 — BLAU FARMACÊUTICA S.A.
CNPJ 58.430.828/0001-60 · listed classes: BLAU3 · CVM code 24627
The full history, year by year
The arrow opens the path from the figure down to the line in the regulator's file. A cell with ! carries a caveat; a dash is a withheld figure — hover for the reason. Nothing is hidden.
| indicator | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| ROE ⟶ | 74.5%! | 68.2% | 81.9% | 104.4% | 35.0% | 21.0% | 13.1% | 10.4% | 13.3% |
| ROIC ⟶ | 49.8%! | 49.7% | 58.5% | 51.7% | 34.4% | 27.0% | 13.2% | 10.9% | 12.2% |
| ROA ⟶ | 28.2%! | 25.7% | 30.1% | 25.3% | 18.0% | 14.9% | 8.9% | 6.6% | 8.4% |
| Gross margin ⟶ | 45.4% | 43.2% | 44.0% | 47.0% | 48.7% | 47.5% | 35.7% | 37.5% | 40.1% |
| EBIT margin ⟶ | 26.6% | 26.0% | 30.8% | 32.9% | 33.4% | 32.1% | 24.0% | 18.7% | 20.8% |
| Net margin ⟶ | 16.7% | 15.8% | 20.5% | 21.5% | 23.7% | 25.6% | 18.0% | 12.2% | 17.4% |
| Revenue growth (1y) ⟶ | — | 26.6% | 25.0% | 20.9% | 15.6% | 3.0% | -2.4% | 27.8% | -3.0% |
| Revenue growth (5y CAGR) ⟶ | — | — | — | — | — | 17.9% | 11.9% | 12.4% | 7.6% |
| Net debt/EBITDA ⟶ | 0.52x | 0.53x | 0.38x | 1.17x | -1.15x | -0.70x | 0.55x | 0.17x | -0.04x |
| Current ratio ⟶ | 1.11x | 2.48x | 1.91x | 2.20x | 4.95x | 4.52x | 4.63x | 3.12x | 2.47x |
The current year, quarter by quarter
As the company filed it in its interim report. The fourth quarter does not exist on its own in that filing — the closed year comes in the annual one, and we do not derive a Q4, so that a figure we computed never sits beside the figures the company reported. Filed on is the date the report became public, and the price is taken from it.
| quarter | revenue | profit | net margin | P/E TTM | P/B | filed on |
|---|---|---|---|---|---|---|
| 2024T1 | 359.7 | 39.7 | 11.0% | 8.3 | 0.98 | 2024-05-09 |
| 2024T2 | 465.1 | 47.6 | 10.2% | 10.9 | 1.15 | 2024-08-26 |
| 2024T3 | 473.6 | 69.2 | 14.6% | 16.1 | 1.44 | 2024-11-06 |
| 2025T1 | 373.0 | 90.7 | 24.3% | 9.1 | 1.10 | 2025-05-06 |
| 2025T2 | 464.8 | 63.2 | 13.6% | 7.6 | 0.95 | 2025-08-06 |
| 2025T3 | 475.2 | 105.5 | 22.2% | 7.2 | 0.97 | 2025-11-04 |
| 2026T1 | 435.0 | 36.3 | 8.3% | 10.0 | 1.06 | 2026-05-07 |
| 2026T2 | 486.6 | 55.5 | 11.4% | 8.2 | 0.82 | 2026-08-11 |
Full series, every quarter: GET /empresas/BLAU3/trimestres
Dividends per year
| year | per share | payments |
|---|---|---|
| 2026 | R$ 0.1515 | 2 |
| 2025 | R$ 1.0243 | 5 |
| 2024 | R$ 0.3643 | 4 |
| 2023 | R$ 0.4223 | 4 |
| 2022 | R$ 0.8497 | 5 |
| 2021 | R$ 0.2481 | 3 |
Piotroski F-Score 5/9 (2025) — what each criterion means.
Restated filings for this company
The regulator overwrites the old version; we keep both. Figures in R$ millions: first filing on the left, restatement on the right.
| fiscal year | account | first filing | restated |
|---|---|---|---|
| 2024 | DRE 3.05 | 328.8 | 361.2 |
| 2024 | DRE 3.07 | 291.9 | 324.3 |
| 2024 | DRE 3.09 | 213.5 | 245.9 |
| 2024 | DRE 3.11 | 213.5 | 245.9 |
| 2017 | BPA 1.01.01 | 13.2 | 9.2 |
| 2017 | BPA 1.01.02 | 0.0 | 4.0 |
| 2024 | DFC_MI 6.01 | 507.2 | 503.3 |
| 2020 | DFC_MI 6.01 | 153.7 | 150.7 |
This company appears in
Other companies in Healthcare
15 more with a page, same CVM sector — a classification of the regulator's, not ours.
Take this into your code
GET /empresas/BLAU3/indicadores. WEGE3 is open for testing without a key; for the rest, create a free key (200 calls/day, no card).Price coverage: 1,345 sessions, 2021-04-19 → 2026-09-04 · methodology · how we verify
Numbers on this page are live. Data version 2026-09-01-supressao-declarada · page generated 2026-09-08 11:12 UTC. If this does not match /saude, you are reading a cached copy.